Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Inhibitor of tropomyosin kinase receptors TRKA,...
Peptide, oxytocin analog; potential OXTR agonis...
δ2OR antagonist.
PI3K and HDAC inhibitor.
Synthetic steroid; glucocorticoid agonist.
T-type calcium channel blocker
Immunodominant peptide epitope occurring in mul...
H1 histamine and LT antagonist, PDE inhibitor.<...
Lincosamide; ribosomal translocation and protei...
Derivative of methyl caffeate, hydroxycinnamic ...
NSAID; COX-1/2 and lipoxygenase inhibitor.
SERM, androgen modulator.
PP2A activator, Sphk1 and PKC inhibitor.
Selective positive allosteric modulator of AMPA...
Carotene pigment found in red and green fruits ...
Inhibitor of CDK.
PERK inhibitor.
Anti-diabetic alkaloid
NMDA potentiator, GABA-A antagonist.
Tryptamine; 5-HT1B/1D agonist, TRPV1 antagonist...